Mertens I - Search Results

1

Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation.

Mertens I, Ballaux D, Funahashi T, Matsuzawa Y, Van der Planken M, Verrijken A, Ruige JB, Van Gaal LF. Mertens I, et al. Thromb Haemost. 2005 Dec;94(6):1190-5. Thromb Haemost. 2005. PMID: 16411393

2

Resting metabolic rate is an important predictor of serum adiponectin concentrations: potential implications for obesity-related disorders.

Ruige JB, Ballaux DP, Funahashi T, Mertens IL, Matsuzawa Y, Van Gaal LF. Ruige JB, et al. Am J Clin Nutr. 2005 Jul;82(1):21-5. doi: 10.1093/ajcn.82.1.21. Am J Clin Nutr. 2005. PMID: 16002795 Clinical Trial.

3

Fasting-based estimates of insulin sensitivity in overweight and obesity: a critical appraisal.

Ruige JB, Mertens IL, Bartholomeeusen E, Dirinck E, Ferrannini E, Van Gaal LF. Ruige JB, et al. Obesity (Silver Spring). 2006 Jul;14(7):1250-6. doi: 10.1038/oby.2006.142. Obesity (Silver Spring). 2006. PMID: 16899806 Free article.

4

Visceral fat as a determinant of fibrinolysis and hemostasis.

Mertens I, Van Gaal LF. Mertens I, et al. Semin Vasc Med. 2005 Feb;5(1):48-55. doi: 10.1055/s-2005-871741. Semin Vasc Med. 2005. PMID: 15968580 Review.

5

Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women?

Mertens I, Van der Planken M, Corthouts B, Van Gaal LF. Mertens I, et al. Metabolism. 2006 May;55(5):650-5. doi: 10.1016/j.metabol.2006.01.001. Metabolism. 2006. PMID: 16631442

6

Hemostasis and fibrinolysis in non-diabetic overweight and obese men and women. Is there still a role for leptin?

Mertens I, Considine RV, Van der Planken M, Van Gaal LF. Mertens I, et al. Eur J Endocrinol. 2006 Sep;155(3):477-84. doi: 10.1530/eje.1.02239. Eur J Endocrinol. 2006. PMID: 16914603

7

PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes.

Mertens I, Lemieux I, Verrijken A, Després JP, Van Gaal LF. Mertens I, et al. Diabetes Metab Res Rev. 2008 Feb;24(2):141-7. doi: 10.1002/dmrr.779. Diabetes Metab Res Rev. 2008. PMID: 17922472

8

Glucose intolerance and the amount of visceral adipose tissue contribute to an increase in circulating triglyceride concentrations in Caucasian obese females.

Berings M, Wehlou C, Verrijken A, Deschepper E, Mertens I, Kaufman JM, Van Gaal LF, Ouwens DM, Ruige JB. Berings M, et al. Among authors: mertens i. PLoS One. 2012;7(9):e45145. doi: 10.1371/journal.pone.0045145. Epub 2012 Sep 28. PLoS One. 2012. PMID: 23028811 Free PMC article. Clinical Trial.

9

Visceral fat is a determinant of PAI-1 activity in diabetic and non-diabetic overweight and obese women.

Mertens I, Van der Planken M, Corthouts B, Wauters M, Peiffer F, De Leeuw I, Van Gaal L. Mertens I, et al. Horm Metab Res. 2001 Oct;33(10):602-7. doi: 10.1055/s-2001-17907. Horm Metab Res. 2001. PMID: 11607880

10

Obesity, haemostasis and the fibrinolytic system.

Mertens I, Van Gaal LF. Mertens I, et al. Obes Rev. 2002 May;3(2):85-101. doi: 10.1046/j.1467-789x.2002.00056.x. Obes Rev. 2002. PMID: 12120424 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters